Bad blood: secrets and lies in a silicon valley startup
Material type: TextPublication details: New York London 2018Description: x, 339 pISBN:- 9781509868070
- 823.92 CAR
Item type | Current library | Collection | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Book | Indian Institute of Management LRC General Stacks | Non-fiction | 823.92 CAR (Browse shelf(Opens below)) | 1 | Available | G00276 | ||
Book | Indian Institute of Management LRC General Stacks | Non-fiction | 823.92 CAR (Browse shelf(Opens below)) | 1 | Available | G00061 |
Browsing Indian Institute of Management LRC shelves, Shelving location: General Stacks, Collection: Non-fiction Close shelf browser (Hides shelf browser)
823.914 RAO Kanthapura | 823.914 SIN Truth, love and a little malice | 823.92 CAR Bad blood: secrets and lies in a silicon valley startup | 823.92 CAR Bad blood: secrets and lies in a silicon valley startup | 823.92 DIX Chase your life dreams: thoughts to change your destiny | 823.92 HUN Murder in the family | 823.92 JOS The illicit happiness of other people |
Now with a new afterword covering the months-long landmark trials of Theranos founders Elizabeth Holmes and Sunny Balwani.
‘I couldn’t put down this thriller . . . a book so compelling that I couldn't turn away’ – Bill Gates
‘A story so incredible you'd think it was fiction' – James Patterson
Winner of the Financial Times/McKinsey Business Book of the Year Award.
The shocking true story of the breathtaking rise and collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes, written by the prize-winning journalist who first broke the story and pursued it to the end.
Seen as the female Steve Jobs, Theranos founder and CEO Elizabeth Holmes was a brilliant Stanford dropout whose startup ‘unicorn’ promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by wealthy investors, Theranos sold shares that valued the company at more than $9 billion.
There was just one problem: the technology didn’t work . . .
Despite threats of legal action, brave whistleblowers started to talk. They revealed a culture of intimidation and secrecy, technology that repeatedly failed, results sent to real patients that were incorrect but upon which life-changing medical decisions were being made, with devastating consequences.
The riveting story behind The Dropout, in Bad Blood, John Carreyrou investigates the biggest corporate fraud since Enron, a tale of ambition and scandal set amid the bold promises of Silicon Valley.
'A tale of corporate fraud and legal browbeating that reads like a crime thriller' - The 10 Best Nonfiction Books, TIME
(https://www.panmacmillan.com/authors/john-carreyrou/bad-blood/9781035006779)
There are no comments on this title.